Olema Pharmaceuticals | ARS: Annual Report to Security Holders
Apr 26 17:21 ET
Olema Pharmaceuticals | DEFA14A: Others
Apr 26 17:15 ET
Olema Pharmaceuticals | DEF 14A: Definitive information statements
Apr 26 17:10 ET
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Harmon Cyrus
Mar 29 17:03 ET
Olema Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 28 11:09 ET
Olema Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(5.44%),Deep Track Biotechnology Master Fund, Ltd.(5.44%), etc.
Mar 22 16:36 ET
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Zojwalla Naseem
Mar 20 17:33 ET
Olema Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 11 16:34 ET
Olema Pharmaceuticals | 10-K: Annual report
Mar 11 16:23 ET
Olema Pharmaceuticals | 8-K: Olema Oncology Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Update
Mar 11 16:09 ET
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director RAPPAPORT ANDREW
Mar 6 17:40 ET
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Harmon Cyrus
Mar 4 17:45 ET
Olema Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 29 14:30 ET
Olema Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Paradigm BioCapital Advisors LP(14.3%),Paradigm BioCapital Advisors GP LLC(14.3%), etc.
Feb 14 17:53 ET
Olema Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Asset Management, LP(4.49%),Bihua Chen(4.49%), etc.
Feb 14 15:13 ET
Olema Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kynam Capital Management, LP(0%),Kynam Capital Management GP, LLC(0%), etc.
Feb 14 12:59 ET
Olema Pharmaceuticals | 424B3: Prospectus
Feb 12 17:22 ET
Olema Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(1.3%)
Feb 12 12:25 ET
Olema Pharmaceuticals | EFFECT: Others
Feb 12 07:08 ET
Olema Pharmaceuticals | CORRESP: CORRESP
Feb 7 22:16 ET
No Data
No Data